Ultrasound in Medicine and Biology
Volume 33, Issue 4 , Pages 561-570 , April 2007

Ultrasonic Assessment of Hepatic Blood Flow as a Marker of Mouse Hepatocarcinoma

  • Philippe Bonnin

      Affiliations

    • Cardiovascular Research Center, INSERM, Lariboisière, INSERM U689, Paris, France
    • AP-HP, hôpital Lariboisière, Physiologie-Explorations Fonctionnelles, Université Paris 7, Paris, France
    • Corresponding Author InformationAddress correspondence to: Dr. Philippe Bonnin, Physiologie-Explorations Fonctionnelles, Hôpital Lariboisière, 2, rue Ambroise Paré, 75 475 Paris CEDEX 10, France.
  • ,
  • Aude Villemain

      Affiliations

    • Cardiovascular Research Center, INSERM, Lariboisière, INSERM U689, Paris, France
    • AP-HP, Institut des Vaisseaux et du Sang, Université Paris 7, Paris, France
  • ,
  • François Vincent

      Affiliations

    • AP-HP, Institut des Vaisseaux et du Sang, Université Paris 7, Paris, France
  • ,
  • Haythem Debbabi

      Affiliations

    • AP-HP, hôpital Lariboisière, Physiologie-Explorations Fonctionnelles, Université Paris 7, Paris, France
  • ,
  • Jean Sébastien Silvestre

      Affiliations

    • Cardiovascular Research Center, INSERM, Lariboisière, INSERM U689, Paris, France
  • ,
  • Jean Olivier Contreres

      Affiliations

    • Cardiovascular Research Center, INSERM, Lariboisière, INSERM U689, Paris, France
    • AP-HP, Institut des Vaisseaux et du Sang, Université Paris 7, Paris, France
  • ,
  • Bernard I. Levy

      Affiliations

    • Cardiovascular Research Center, INSERM, Lariboisière, INSERM U689, Paris, France
    • AP-HP, hôpital Lariboisière, Physiologie-Explorations Fonctionnelles, Université Paris 7, Paris, France
  • ,
  • Gérard Tobelem

      Affiliations

    • Cardiovascular Research Center, INSERM, Lariboisière, INSERM U689, Paris, France
    • AP-HP, Institut des Vaisseaux et du Sang, Université Paris 7, Paris, France
  • ,
  • Evelyne Dupuy

      Affiliations

    • Cardiovascular Research Center, INSERM, Lariboisière, INSERM U689, Paris, France
    • AP-HP, Institut des Vaisseaux et du Sang, Université Paris 7, Paris, France

Received 18 April 2006 ,Revised 11 September 2006 ,Accepted 26 September 2006.

References 

  1. Bergers G, Hanahan D, Coussens LM. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Int J Dev Biol. 1998;42:995–1002
  2. Blomley MJ, Eckersley RJ. Functional ultrasound methods in oncological imaging. Eur J Cancer. 2002;38:2108–2115
  3. Bogers HA, Sedelaar JP, Beerlage HP, et al. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: Correlation with biopsy outcome. Urology. 1999;54:97–104
  4. British Standards Institution. Precision of Test Method (BS5497, part 1). London: BSI; 1979;
  5. Brown AS, Leamen L, Cucevic V, Foster FS. Quantitation of hemodynamic function during developmental vascular regression in the mouse eye. Invest Ophthalmol Vis Sci. 2005;46:2231–2237
  6. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249–257
  7. Chaves AA, Weinstein DM, Bauer JA. Non-invasive echocardiographic studies in mice: influence of anesthetic regimen. Life Sci. 2001;69:213–222
  8. Cheung AM, Brown AS, Hastie LA, et al. Three-dimensional ultrasound biomicroscopy for xenograft growth analysis. Ultrasound Med Biol. 2005;31:865–870
  9. Collins KA, Korcarz CE, Lang RM. Use of echocardiography for the phenotypic assessment of genetically altered mice. Physiol Genomics. 2003;13:227–239
  10. D’Angelo MG, Afanasieva T, Aguzzi A. Angiogenesis in transgenic models of multistep carcinogenesis. J Neurooncol. 2000;50:89–98
  11. Davis DW, McConkey DJ, Abbruzzese JL, Herbst RS. Surrogate markers in antiangiogenesis clinical trials. Br J Cancer. 2003;89:8–14
  12. Ding H, Kudo M, Onda H, et al. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: Comparison with dynamic CT. Radiology. 2001;221:721–730
  13. Dubois N, Bennoun M, Allemand I, et al. Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice. J Hepatol. 1991;13:227–239
  14. Dupuy E, Hainaud P, Villemain A, et al. Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model. J Hepatol. 2003;38:793–802
  15. Folkman J. Angiogenesis-dependent diseases. Semin Oncol. 2001;28:536–542
  16. Fox SB, Gasparini G, Harris AL. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol. 2001;2:278–289
  17. Gee MS, Saunders HM, Lee JC, et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res. 2001;61:2974–2982
  18. Hoit BD, Kiatchoosakun S, Restivo J, et al. Naturally occurring variation in cardiovascular traits among inbred mouse strains. Genomics. 2002;79:679–685
  19. Iordanescu I, Becker C, Zetter B, Dunning P, Taylor GA. Tumor vascularity: Evaluation in a murine model with contrast-enhanced color Doppler US-effect of angiogenesis inhibitors. Radiology. 2002;222:460–467
  20. Jakab F, Rath Z, Schmal F, Nagy P, Faller J. Changes in hepatic hemodynamics due to primary liver tumours. HPB Surg. 1996;9:245–248
  21. Jouannot E, Duong-Van-Huyen J, Bourahla K, Laugier P, Lelievre-Pegorier M, Bridal L. High-frequency ultrasound detection and follow-up of Wilms’ tumor in the mouse. Ultrasound Med Biol. 2006;32:183–190
  22. Kiessling F, Greschus S, Lichy MP, et al. Volumetric computed tomography (VCT): A new technology for noninvasive, high-resolution monitoring of tumor angiogenesis. Nat Med. 2004;10:1133–1138
  23. Kim CK, Lim JH, Park CK, Choi D, Lim HK, Lee WJ. Neoangiogenesis and sinusoidal capillarization in hepatocellular carcinoma: Correlation between dynamic CT and density of tumor microvessels. Radiology. 2005;237:529–534
  24. Kissel A, Rixe O, Methlin A, et al. Quantification of hepatic arterial and portal venous flow using ultrasound contrast agents for early detection of liver metastases of colorectal cancers. J Radiol. 2001;82:1621–1625
  25. Krix M, Kiessling F, Vosseler S, et al. Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography. Cancer Res. 2003;63:8264–8270
  26. Kunishima S, Taniguchi H, Yamaguchi A, Koh T, Yamagishi H. Changes in hepatic parenchymal blood flow with colorectal metastases: Increase in arterial and decrease in portal blood flow. Hepatogastroenterology. 2003;50:1457–1462
  27. McDonald DM, Choyke PL. Imaging of angiogenesis: From microscope to clinic. Nat Med. 2003;9:713–725
  28. McVeigh ER. Emerging imaging techniques. Circ Res. 2006;98:879–886
  29. Masaki T, Ohkawa S, Amano A, Ueno M, Miyakawa K, Tarao K. Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer. 2005;103:1026–1035
  30. Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND. Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol. 1998;22:656–662
  31. Phoon CK. Imaging tools for the developmental biologist: Ultrasound biomicroscopy of mouse embryonic development. Pediatr Res. 2006;60:14–21
  32. Roth DM, Swaney JS, Dalton ND, Gilpin EA, Ross J. Impact of anesthesia on cardiac function during echocardiography in mice. Am J Physiol Heart Circ Physiol. 2002;282:H2134–H2140
  33. Saftoiu A, Ciurea T, Gorunescu F. Hepatic arterial blood flow in large hepatocellular carcinoma with or without portal vein thrombosis: Assessment by transcutaneous duplex Doppler sonography. Eur J Gastroenterol Hepatol. 2002;14:167–176
  34. Scappaticci FA. Mechanisms and future directions for angiogenesis-based cancer therapies. J Clin Oncol. 2002;20:3906–3927
  35. Sedelaar JP, van Leenders GJ, Hulsbergen-van de Kaa CA, et al. Microvessel density: Correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol. 2001;40:285–293
  36. Sell S. Mouse models to study the interaction of risk factors for human liver cancer. Cancer Res. 2003;63:7553–7562
  37. Silvestre JS, Mallat Z, Duriez M, et al. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res. 2000;87:448–452
  38. Sugimoto H, Kaneko T, Hirota M, Inoue S, Takeda S, Nakao A. Physical hemodynamic interaction between portal venous and hepatic arterial blood flow in humans. Liver Int. 2005;25:282–287
  39. Tatsumi M, Nakamoto Y, Traughber B, Marshall LT, Geschwind JF, Wahl RL. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose. Cancer Res. 2003;63:6252–6257
  40. Wanless IR. Anatomy, histology, embryology, and developmental anomalies of the liver. In:  Feldman M,  Friedman LS,  Sleisenger MV editor. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. Philadelphia, PA: Elsevier Science; 2002;p. 1195–1201
  41. Wikström J, Grönros J, Bergström G, Gan LM. Functional and morphologic imaging of coronary atherosclerosis in living mice using high-resolution color Doppler echocardiography and ultrasound biomicroscopy. J Am Coll Cardiol. 2005;46:720–727
  42. Yamagami T, Arai Y, Takeuchi Y, et al. Increased hepatic arterial blood flow after decreased portal supply to the liver parenchyma owing to intrahepatic portosystemic venous shunt: angiographic demonstration using helical CT. Br J Radiol. 2000;73:1042–1045
  43. Zheng XH, Guan YS, Zhou XP, et al. Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT. World J Gastroenterol. 2005;11:200–203

PII: S0301-5629(06)01863-1

doi: 10.1016/j.ultrasmedbio.2006.09.010

Ultrasound in Medicine and Biology
Volume 33, Issue 4 , Pages 561-570 , April 2007